The present invention relates to a pharmaceutical composition comprising propiverine, trospium or glycopyrrolate

Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of extended release trospium, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of pilocarpine, or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder, the method comprising identifying a patient in need thereof, and administering to the patient a therapeutically effective amount of ext...

A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.

A pharmaceutical composition of a pharmaceutically acceptable trospium salt with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml respectively.

Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of extended release trospium or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder the method comprising identifying a patient in need thereof and administering to the patient a therapeutically effective amount of extended...

Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of immediate release trospium or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder the method comprising identifying a patient in need thereof and administering to the patient a therapeutically effective amount of immedia...

Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of immediate release trospium or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder the method comprising identifying a patient in need thereof and administering to the patient a therapeutically effective amount of immedia...

Disclosed herein are pharmaceutical compositions comprising a therapeutically effective amount of extended release trospium or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of pilocarpine or a pharmaceutically acceptable salt thereof. Also disclosed herein are methods of treating a patient suffering from overactive bladder the method comprising identifying a patient in need thereof and administering to the patient a therapeutically effective amount of extended...